PCA3 molecular urine assay for prostate cancer: association with pathologic features and impact of collection protocols

INTRODUCTION: PCA3 is a non-coding mRNA molecule that is overexpressed in prostate cancer. The purpose of this study is to evaluate the utility of the PCA3 molecular urine test scores to predict adverse pathologic features and catheterized specimen collection. METHODS: Hundred men with clinically lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Liss, Michael A., Santos, Rosanne, Osann, Kathryn, Lau, Alice, Ahlering, Thomas E., Ornstein, David K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189407/
https://www.ncbi.nlm.nih.gov/pubmed/21152924
http://dx.doi.org/10.1007/s00345-010-0623-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189407/
https://www.ncbi.nlm.nih.gov/pubmed/21152924
http://dx.doi.org/10.1007/s00345-010-0623-6

Ejemplares similares